Generally NRAS gene mutation is associated with tumor progression and was reported to be associated with poor prognosis in solid tumors and acute lymphoblastic leukemia (ALL).31,32 Published reports addressing the clinical significance of NRAS mutations in patients with acute myeloid leukemia are inconclusive. The gene discussed is NRAS; the disease is acute myeloid leukemia.